Venetoclax (ABT-199) in Patients with Chronic Lymphocytic Leukemia: Experience through the Pre-Approval Access Program in European Countries: A Medical ChartReview (ExPloReR)

03/12/2019
14/03/2024
EU PAS number:
EUPAS32308
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

H17-215 (EXPLORER) Final Protocol_Redacted

English (1.22 MB - PDF) View document
Study results
Study results

H17-215 Results Abstract

English (132.52 KB - PDF) View document
Study report
Other information